Schedule of Segment Information (Details) - USD ($) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
|||||
| Research and development: | ||||||
| Clinical | $ 5,632,217 | $ 2,613,188 | ||||
| Non-clinical | 2,260,300 | 3,888,787 | ||||
| Other | [1] | 462,787 | (764,723) | |||
| Total research and development | 8,355,304 | 5,737,252 | ||||
| General and administrative: | ||||||
| Payroll and related | 1,716,552 | 715,846 | ||||
| Professional fees | 3,695,790 | 1,922,292 | ||||
| Consulting | 1,314,698 | 1,532,601 | ||||
| Other | [2] | 1,761,771 | 1,960,106 | |||
| Total general and administrative | 8,488,811 | 6,130,845 | ||||
| Total operating expenses | $ 16,844,115 | $ 11,868,097 | ||||
| ||||||
| X | ||||||||||
- Definition Clinical expenses. No definition available.
|
| X | ||||||||||
- Definition Consulting fees. No definition available.
|
| X | ||||||||||
- Definition Non clinical expenses. No definition available.
|
| X | ||||||||||
- Definition Other research and development. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|